Henry Klingenstein is a Partner at ARTIS Ventures where he invests in seed and early-stage companies across healthcare technologies, computational medicine, TechBio, and machine-learning-driven diagnostics. He is based in San Francisco and invests across the San Francisco Bay Area, West Coast, and Western US. He has invested in companies including Eko, Ozlo Sleep, Climax Foods, ONI, Mytos, FIG, Glyphic, and Locus. Before ARTIS Ventures, he was Head of Strategy & Product Development (co-founder) at Spur Laboratories, a Researcher at the University of Chicago Booth School of Business, and held Manager and Associate roles at Quid. He studied at Stanford University Graduate School of Business.
Henry Klingenstein, Partner @ ARTIS. Profile with intro opportunities and ranking information.
Not Yet Mapped
We've created a profile for Henry Klingenstein from ARTIS Ventures. Our ranking analysis and additional data will be available once our research is complete.
Rankings and detailed information coming soon
Network Strength
No ranking data available yet.
How to get an intro to Henry
Map your path to Henry instantly
Connect your network and Draftboard will automatically find and score the strongest paths to Henry
That's it. Draftboard does the rest.
Rankings based on connection strength analysis - we ONLY show aggregate data, never specific connection data.